Related references
Note: Only part of the references are listed.Long-term MRI-guided combined anti-TNF-a and thiopurine therapy for crohn's perianal fistulas
Phil Tozer et al.
INFLAMMATORY BOWEL DISEASES (2012)
OP20 TNF and MDP induce epithelial-to-mesenchymal transition in human intestinal cells: Implications for the pathogenesis of Crohn's disease-associated fistulae and the use of anti-TNF antibodies
M. Scharl et al.
Journal of Crohns & Colitis (2012)
Long-Term Monitoring of Infliximab Therapy for Perianal Fistulizing Crohn's Disease by Using Magnetic Resonance Imaging
Konstantinos Karmiris et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
An open study of maintenance antibiotic therapy for chronic antibiotic-dependent pouchitis: efficacy, complications and outcome
S. D. McLaughlin et al.
COLORECTAL DISEASE (2011)
Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease
Rachele Ciccocioppo et al.
GUT (2011)
The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn's disease who failed prior infliximab therapy
S. Lichtiger et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Prospective Evaluation of Anti-Tumor Necrosis Factor Therapy Guided by Magnetic Resonance Imaging for Crohn's Perineal Fistulas
Siew C. Ng et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Adalimumab for the treatment of fistulas in patients with Crohn's disease
J-F Colombel et al.
GUT (2009)
Ciprofloxacin or Metronidazole for the Treatment of Perianal Fistulas in Patients with Crohn's Disease: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
Kelvin T. Thia et al.
INFLAMMATORY BOWEL DISEASES (2009)
Impact of demographic factors, medication and symptoms on disease-specific quality of life in inflammatory bowel disease
Johanna Haapamaki et al.
QUALITY OF LIFE RESEARCH (2009)
Early stopping of randomized clinical trials for overt efficacy is problematic
Dirk Bassler et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)
Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open-label, multicentre trial
J. Hinojosa et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2007)
Systematic review: the management of pouchitis
DS Pardi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Infliximab maintenance therapy for fistulizing Crohn's disease
BE Sands et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study
RL West et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease
G Van Assche et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2003)
The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota
DA Schwartz et al.
GASTROENTEROLOGY (2002)
Endosonographic evidence of persistence of Crohn's disease-associated fistulas after infliximab treatment, irrespective of clinical response
AA van Bodegraven et al.
DISEASES OF THE COLON & RECTUM (2002)
Preliminary study of ciprofloxacin in active Crohn's disease
GL Arnold et al.
INFLAMMATORY BOWEL DISEASES (2002)
Diagnosis and treatment of perianal fistulas in Crohn disease
DA Schwartz et al.
ANNALS OF INTERNAL MEDICINE (2001)
Share Paper
